iPRIME – innovative Promotionsförderung im Bereich translationale Entzündungsforschung
About 5-8% of the world’s population is affected by autoimmune diseases. The immune system attacks the own body and can cause severe inflammatory reactions in various organs. Unfortunately, the existing therapies are often unspecific and can sometimes trigger serious side effects.
Therefore, the aim of the interdisciplinary iPRIME program is to combine the research on the different organs such as kidney, liver, brain, intestine or placenta in order to develop new therapies. The medical students participating in the iPRIME program have the opportunity to complete their MD thesis in various fields dealing with immunology and inflammation and benefit from a structured training program and an individual supervision concept.
Here you can get further information.